skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 138,976  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Refined by: subject: Care And Treatment remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
Material Type:
Article 		Add to My Research

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

Molecular cancer, 2023-08, Vol.22 (1), p.1-138, Article 138 [Peer Reviewed Journal]

COPYRIGHT 2023 BioMed Central Ltd. ;2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution ;BioMed Central Ltd., part of Springer Nature 2023 ;ISSN: 1476-4598 ;EISSN: 1476-4598 ;DOI: 10.1186/s12943-023-01827-6 ;PMID: 37596643

Full text available

Citations Cited by
2
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
Material Type:
Article 		Add to My Research

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

Journal of experimental & clinical cancer research, 2019-06, Vol.38 (1), p.255-255, Article 255 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1259-z ;PMID: 31196207

Full text available

Citations Cited by
3
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review
Material Type:
Article 		Add to My Research

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

PloS one, 2013-08, Vol.8 (8), p.e71583 [Peer Reviewed Journal]

COPYRIGHT 2013 Public Library of Science ;COPYRIGHT 2013 Public Library of Science ;2013 Franciosi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Franciosi et al 2013 Franciosi et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0071583 ;PMID: 23936520

Full text available

Citations Cited by
4
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
PD-1 blockade inhibits osteoclast formation and murine bone cancer pain
Material Type:
Article 		Add to My Research

PD-1 blockade inhibits osteoclast formation and murine bone cancer pain

The Journal of clinical investigation, 2020-07, Vol.130 (7), p.3603-3620 [Peer Reviewed Journal]

COPYRIGHT 2020 American Society for Clinical Investigation ;COPYRIGHT 2020 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Jul 2020 ;2020 American Society for Clinical Investigation 2020 American Society for Clinical Investigation ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci133334 ;PMID: 32484460

Full text available

Citations Cited by
5
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Material Type:
Article 		Add to My Research

Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy

Journal of hematology and oncology, 2019-05, Vol.12 (1), p.54-54, Article 54 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0738-1 ;PMID: 31151482

Full text available

Citations Cited by
6
TIM-3, a promising target for cancer immunotherapy
TIM-3, a promising target for cancer immunotherapy
Material Type:
Article 		Add to My Research

TIM-3, a promising target for cancer immunotherapy

OncoTargets and therapy, 2018-01, Vol.11, p.7005-7009 [Peer Reviewed Journal]

COPYRIGHT 2018 Dove Medical Press Limited ;COPYRIGHT 2018 Dove Medical Press Limited ;2018. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 He et al. This work is published and licensed by Dove Medical Press Limited 2018 ;ISSN: 1178-6930 ;EISSN: 1178-6930 ;DOI: 10.2147/ott.s170385 ;PMID: 30410357

Full text available

Citations Cited by
7
Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis
Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis

BMC cancer, 2019-06, Vol.19 (1), p.589-589, Article 589 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5791-1 ;PMID: 31208348

Full text available

Citations Cited by
8
Plasma free amino acid profiling of five types of cancer patients and its application for early detection
Plasma free amino acid profiling of five types of cancer patients and its application for early detection
Material Type:
Article 		Add to My Research

Plasma free amino acid profiling of five types of cancer patients and its application for early detection

PloS one, 2011-09, Vol.6 (9), p.e24143-e24143 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Miyagi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Miyagi et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0024143 ;PMID: 21915291

Full text available

Citations Cited by
9
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Material Type:
Article 		Add to My Research

Nanotechnology in cancer diagnosis: progress, challenges and opportunities

Journal of hematology and oncology, 2019-12, Vol.12 (1), p.137-137, Article 137 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0833-3 ;PMID: 31847897

Full text available

Citations Cited by
10
Portrait of a cancer: mutational signature analyses for cancer diagnostics
Portrait of a cancer: mutational signature analyses for cancer diagnostics
Material Type:
Article 		Add to My Research

Portrait of a cancer: mutational signature analyses for cancer diagnostics

BMC cancer, 2019-05, Vol.19 (1), p.457-457, Article 457 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5677-2 ;PMID: 31092228

Full text available

Citations Cited by
11
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis
Material Type:
Article 		Add to My Research

Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis

Breast cancer (Tokyo, Japan), 2021-11, Vol.28 (6), p.1167-1180 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 1340-6868 ;EISSN: 1880-4233 ;DOI: 10.1007/s12282-020-01148-2

Digital Resources/Online E-Resources

Citations Cited by
12
BMI-1, a promising therapeutic target for human cancer
BMI-1, a promising therapeutic target for human cancer
Material Type:
Article 		Add to My Research

BMI-1, a promising therapeutic target for human cancer

Oncology letters, 2015-08, Vol.10 (2), p.583-588 [Peer Reviewed Journal]

Copyright © 2015, Spandidos Publications ;COPYRIGHT 2015 Spandidos Publications ;COPYRIGHT 2015 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2015 ;Copyright © 2015, Spandidos Publications 2015 ;ISSN: 1792-1074 ;EISSN: 1792-1082 ;DOI: 10.3892/ol.2015.3361 ;PMID: 26622537

Full text available

Citations Cited by
13
Emerging organoid models: leaping forward in cancer research
Emerging organoid models: leaping forward in cancer research
Material Type:
Article 		Add to My Research

Emerging organoid models: leaping forward in cancer research

Journal of hematology and oncology, 2019-12, Vol.12 (1), p.142-142, Article 142 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-8722 ;EISSN: 1756-8722 ;DOI: 10.1186/s13045-019-0832-4 ;PMID: 31884964

Full text available

Citations Cited by
14
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways
Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways
Material Type:
Article 		Add to My Research

Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways

Journal of experimental & clinical cancer research, 2019-02, Vol.38 (1), p.93-93, Article 93 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;Copyright © 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1756-9966 ;ISSN: 0392-9078 ;EISSN: 1756-9966 ;DOI: 10.1186/s13046-019-1109-z ;PMID: 30791957

Full text available

Citations Cited by
15
ZFAS1 : a novel tumor-related long non-coding RNA
ZFAS1 : a novel tumor-related long non-coding RNA
Material Type:
Article 		Add to My Research

ZFAS1 : a novel tumor-related long non-coding RNA

Cancer cell international, 2018-09, Vol.18 (1), p.125-125, Article 125 [Peer Reviewed Journal]

Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 1475-2867 ;EISSN: 1475-2867 ;DOI: 10.1186/s12935-018-0623-y ;PMID: 30186041

Full text available

Citations Cited by
16
HER2-targeted therapies - a role beyond breast cancer
HER2-targeted therapies - a role beyond breast cancer
Material Type:
Article 		Add to My Research

HER2-targeted therapies - a role beyond breast cancer

Nature reviews. Clinical oncology, 2020-01, Vol.17 (1), p.33-48 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Jan 2020 ;ISSN: 1759-4774 ;EISSN: 1759-4782 ;DOI: 10.1038/s41571-019-0268-3 ;PMID: 31548601

Full text available

Citations Cited by
17
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
Material Type:
Article 		Add to My Research

Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.671-686 [Peer Reviewed Journal]

The Author(s) 2017 ;COPYRIGHT 2018 Springer ;Breast Cancer Research and Treatment is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0167-6806 ;ISSN: 1573-7217 ;EISSN: 1573-7217 ;DOI: 10.1007/s10549-017-4537-5 ;PMID: 29063313

Full text available

Citations Cited by
18
Annexin A2 and cancer: A systematic review
Annexin A2 and cancer: A systematic review
Material Type:
Article 		Add to My Research

Annexin A2 and cancer: A systematic review

International journal of oncology, 2018-01, Vol.52 (1), p.5-18

COPYRIGHT 2018 Spandidos Publications ;COPYRIGHT 2018 Spandidos Publications ;Copyright Spandidos Publications UK Ltd. 2018 ;ISSN: 1019-6439 ;EISSN: 1791-2423 ;DOI: 10.3892/ijo.2017.4197

Full text available

Citations Cited by
19
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Material Type:
Article 		Add to My Research

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

PloS one, 2012-03, Vol.7 (3), p.e33411-e33411 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Noto et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Noto et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0033411 ;PMID: 22448244

Full text available

Citations Cited by
20
Mechanism of Citri Reticulatae Pericarpium as an Anticancer Agent from the Perspective of Flavonoids: A Review
Mechanism of Citri Reticulatae Pericarpium as an Anticancer Agent from the Perspective of Flavonoids: A Review
Material Type:
Article 		Add to My Research

Mechanism of Citri Reticulatae Pericarpium as an Anticancer Agent from the Perspective of Flavonoids: A Review

Molecules (Basel, Switzerland), 2022-08, Vol.27 (17), p.5622 [Peer Reviewed Journal]

COPYRIGHT 2022 MDPI AG ;2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 1420-3049 ;EISSN: 1420-3049 ;DOI: 10.3390/molecules27175622 ;PMID: 36080397

Full text available

Citations Cited by

Results 1 - 20 of 138,976  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (119,870)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1989  (34)
  2. 1989 To 1996  (305)
  3. 1997 To 2004  (2,742)
  4. 2005 To 2013  (32,024)
  5. After 2013  (103,877)
  6. More options open sub menu

Subject 

  1. Science & Technology  (108,123)
  2. Life Sciences & Biomedicine  (98,999)
  3. Cancer  (75,394)
  4. Humans  (60,357)
  5. Oncology  (59,532)
  6. Health Aspects  (56,190)
  7. Tumors  (35,985)
  8. Cancer Therapies  (33,687)
  9. Diagnosis  (32,424)
  10. Patients  (32,012)
  11. Female  (30,441)
  12. Chemotherapy  (30,186)
  13. Metastasis  (29,142)
  14. Development And Progression  (27,856)
  15. Genetic Aspects  (26,254)
  16. Analysis  (25,444)
  17. Breast Cancer  (23,730)
  18. Male  (23,149)
  19. Patient Outcomes  (21,361)
  20. More options open sub menu

Language 

  1. English  (138,862)
  2. Japanese  (13,331)
  3. Portuguese  (244)
  4. Turkish  (190)
  5. French  (161)
  6. Spanish  (86)
  7. Norwegian  (64)
  8. Chinese  (52)
  9. Russian  (13)
  10. Afrikaans  (7)
  11. German  (3)
  12. Welsh  (2)
  13. Italian  (1)
  14. Serbian  (1)
  15. Croatian  (1)
  16. Bulgarian  (1)
  17. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait